Burns, Douglas M., Lisa Stehno-Bittel, and Tomoyuki Kawase. Calcitonin gene-related peptide elevates calcium and polarizes membrane potential in MG-63 cells by both cAMP-independent and -dependent mechanisms. Am J Physiol Cell Physiol 287: C457-C467, 2004; 10.1152/ajpcell.00274.2003.-Published data suggest that the neuropeptide calcitonin gene-related peptide (CGRP) can stimulate osteoblastic bone formation; however, interest has focused on activation of cAMP-dependent signaling pathways in osteogenic cells without full consideration of the importance of cAMPindependent signaling. We have now examined the effects of CGRP on intracellular Ca 2ϩ concentration ([Ca 2ϩ ]int) and membrane potential (Em) in preosteoblastic human MG-63 cells by single-cell fluorescent confocal analysis using fluo 4-AM-fura red-AM and bis(1,3-dibarbituric acid)-trimethine oxanol [DiBAC4(3)] bis-oxonol assays. CGRP produced a two-stage change in [Ca 2ϩ ]int: a rapid transient peak and a secondary sustained increase. Both responses were dose dependent with an EC50 of ϳ0.30 nM, and the maximal effect (initially ϳ3-fold over basal levels) was observed at 20 nM. The initial phase was sensitive to inhibition of Ca 2ϩ mobilization with thapsigargin, whereas the secondary phase was eliminated only by blocking transmembrane Ca 2ϩ influx with verapamil or inhibiting cAMP-dependent signaling with the Rp isomer of adenosine 3Ј,5Ј-cyclic monophosphorothioate (Rp-cAMPS). These data suggest that CGRP initially stimulates Ca 2ϩ discharge from intracellular stores by a cAMP-independent mechanism and subsequently stimulates Ca 2ϩ influx through L-type voltage-dependent Ca 2ϩ channels by a cAMP-dependent mechanism. In addition, CGRP dosedependently polarized cellular Em, with maximal effect at 20 nM and an EC50 of 0.30 nM. This effect was attenuated with charybdotoxin (Ϫ20%) or glyburide (glibenclamide; Ϫ80%), suggesting that Em hyperpolarization is induced by both Ca 2ϩ -activated and ATP-sensitive K ϩ channels. Thus CGRP signals strongly by both cAMP-dependent and cAMP-independent signaling pathways in preosteoblastic human MG-63 cells. osteoblastic cells; calcium; membrane potential; potassium channels; adenosine 3Ј,5Ј-cyclic monophosphate OVER THE PAST 15 YEARS evidence has accumulated indicating that peripheral peptidergic neurons can influence cells within target tissues through localized release of neuropeptides (2, 14 -17, 23, 27, 41). One important peripheral neuroeffector that may play a role in bone metabolism is ␣-calcitonin gene-related peptide (CGRP), a 37-residue peptide produced in specific neurons by alternative splicing of the primary transcript from the calcitonin gene (10).
Numerous publications provide in vivo demonstration that CGRP innervation is associated with bone formation (and similar mineralizing processes), particularly during development, growth, or repair (for detailed review, see Refs. 16 and 17) . In vitro studies have demonstrated that CGRP stimulates the osteoblastic differentiation of bone marrow mesenchymal stromal cells (32, 33) and acts directly on osteoblastic cells to modulate phenotypic functions (7, 29, 37) . These and similar data suggested that neuroactive CGRP plays a role in stimulating or maintaining bone formation in skeletal tissues. In further support of the bone anabolic action of CGRP, Vignery and coworkers demonstrated that CGRP protects against ovariectomy-induced bone loss (36) and that targeted transgenic expression of CGRP in mouse osteoblasts increases bone density 27-40% at skeletal sites by stimulating cancellous bone formation (1) .
Despite data suggesting that CGRP can stimulate bone formation, its mechanism of action in osteoblast-related cells is not well understood. Historically, attention was drawn to CGRP's pronounced stimulation of cAMP formation in immature osteoblast-related cells isolated from bone and bone linings from several species (28) , but this cAMP response varies considerably in different osteoblastic cell types (Refs. 3, 19 , and 28; Burns and Kawase, unpublished observations). In addition, we (18, 20, 21) and others (11, 12, 38, 39) have recently reported that CGRP can stimulate cAMP-independent intracellular signaling pathways in several osteoblastic cell types. We thought it significant that mature osteoblast-like cells respond to CGRP by increasing intracellular Ca 2ϩ ([Ca 2ϩ ] int ) and/or altering membrane potential (E m ) while yielding small increases (if any) in cAMP production (18, 20, 21) . Similarly, Drissi et al. (11, 12) demonstrated that CGRP increases [Ca 2ϩ ] int , but not cAMP, in human OHS-4 osteoblast-like cells. Recently, Villa et al. (38, 39) demonstrated that CGRP's 2.2-fold stimulation of proliferation in primary cultures of human osteoblasts is cAMP independent. Collectively, these data suggest that cAMP may not represent the primary mode of CGRP signaling in mature osteoblastic cells.
From among an assortment of osteoblast-like cell lines, clonal osteosarcoma-derived human MG-63 cells have been described as a model for early-stage immature preosteoblasts because of the nature of their response to factors like l,25(OH) 2 -vitamin D 3 and their regulated temporal development of bone-type alkaline phosphatase activity (4, 9) . We very recently found (22) that MG-63 cells prominently express the type-1 CGRP receptor [calcitonin receptor-like receptor (CRLR)/receptor activity-modifying protein (RAMP)1] and respond to CGRP with 35-fold increases in cAMP formation and rapid phosphorylation or dephosphorylation of several types of mitogen-activated protein kinase. Similar strong cAMP signaling has also been reported for immature lining and preosteoblastic cells (3, 19, 28, 34) , and this correlation suggests that cAMP and cAMP-dependent pathways could be the primary mode of CGRP signaling in immature osteogenic cells.
Thus it was of considerable interest to determine whether CGRP also induces changes in [Ca 2ϩ ] int or cellular E m in preosteoblastic human MG-63 cells. To this end, we have employed a sensitive, single whole cell fluorescent confocal analysis using a fluo 4-AM-Fura red-AM ratiometric assay to assay [Ca 2ϩ ] int and similarly modified our bis(1,3-dibarbituric acid)-trimethine oxanol [DiBAC 4 (3) ] bis-oxonol assay to monitor E m . Expecting to find modest or negligible effects of CGRP on these parameters, we have instead demonstrated robust effects that exceed in complexity and magnitude those we had previously observed in a more mature model of osteogenic cells (18, 20, 21) . In addition, we also report unexpected differences between our present results and our previous findings, including CGRP's activation of cAMPdependent, verapamil-sensitive membrane Ca 2ϩ channels to produce a long-sustained Ca 2ϩ increase in MG-63 cells. Although cAMP-independent mechanisms figure into induction of the initial Ca 2ϩ transient and polarization of E m as previously observed in UMR106 cells, the situation is substantially more complex in preosteoblastic MG-63 cells and could conceivably involve additional CGRP receptor subtypes.
MATERIALS AND METHODS

Materials.
Human CGRP (Advanced Chemtech, Louisville, KY) was dissolved in 0.01% trifluoroacetic acid to a stock concentration of 100 M and stored in 50-l aliquots at Ϫ40°C; necessary dilutions were made immediately before use. Charybdotoxin (Sigma-Aldrich, St. Louis, MO) and adenosine-3Ј,5Ј-cyclic monophosphorothioate, Rp isomer, triethylammonium salt (Rp-cAMPS; Calbiochem, La Jolla, CA) were dissolved in distilled water to concentrations of 500 g/ml and 5 mM, respectively. Glyburide (glibenclamide; Sigma-Aldrich) and charybdotoxin were dissolved in DMSO to 2 and 20 mM, respectively. Fluo 4-AM and fura red-AM were dissolved in DMSO to 1 and 4 mM, respectively. DiBAC 4(3) (Molecular Probes, Eugene, OR) was dissolved in ethanol to 20 mM. Thapsigargin (SigmaAldrich) was dissolved in DMSO to a stock concentration of 10 mM.
Cells and cell cultures. Low-passage MG-63 osteogenic human osteosarcoma cells were obtained from the American Type Culture Collection (Manassas, VA) and plated, grown, and maintained in DMEM supplemented with 1 mM L-glutamine, standard penicillinstreptomycin, and 2% fetal bovine serum (FBS; JRH Biosciences, Mission, KS). Cells were normally plated at a density of 1 ϫ 10 3 cells/cm 2 and cultivated in humidified 5% CO2-95% air at 37°C. Cultures were never allowed to become confluent. For the assays described below, cells were grown on sterile 1-mm-thick, 23-mmdiameter circular coverslips. All assays were performed in physiological saline solution (PSS; in mM: 130 NaCl, 5 KCl, 1.5 CaCl 2, 1 glucose, 10 HEPES, pH 7.30).
Measurement of [Ca 2ϩ ]int. The data reported here were obtained with detailed single-cell measurements of [Ca 2ϩ ]int using the dual-dye ratiometric method of Lipp and Niggli (25, 26) and laser-scanning fluorescent confocal microscopy. In this protocol, subconfluent densities of MG-63 cells grown on circular 1-mm-thick coverslips were loaded for 30 min with 1 M fluo 4-AM and 4 M fura red-AM in standard DMEM supplemented with 1% FBS. Slides were rinsed twice with PSS ϩ 0.2% FBS, mounted individually to a 23-mmdiameter Attafluor slide chamber (Molecular Probes), immersed in 1 ml of PSS ϩ 0.2% FBS, and then examined at 22°C on the stage of an inverted Nikon Eclipse T-300 microscope equipped for fluorescent dark-field imaging and coupled directly to a Bio-Rad RadiancePlus 2000 triple-laser computer-controlled scanning confocal apparatus (Bio-Rad Laboratories, Hercules, CA).Experimental treatments were introduced by withdrawing 400 l of the chamber bath volume, into which was mixed the desired treatment (peptide or reagent). This solution was carefully introduced back into the slide-holding chamber with careful mixing, thus avoiding exposure of cells to unusually high levels of vehicle or treatment reagent.
To estimate [Ca 2ϩ ], dye-loaded cells were excited with the 488-nm line of an argon laser running at approximately Ͻ1.5 mW. The standard confocal pinhole setting for this assay was 3.2 mm, and when emissions were collected with the ϫ40 or ϫ60 objectives the "optical slice" was typically 0.6 m thick. Fluo 4 emission at 520 Ϯ 15 nm strongly increases as [Ca 2ϩ ] increases, whereas fura red emission at 620 Ϯ 40 nm decreases as [Ca 2ϩ ] increases. These two emissions from individual mouse-delineated cellular cross sections were collected in separate channels. General cellular fluorescence was found to be so low as to be negligible in these confocal assays, but backgrounds were still collected in each assay.
Time course profiles were initially collected as raw data (total pixels within a computer-designated cellular cross section for each designated emission), and a background time course (equivalent areas without cells, or identical cells without dye) was collected and stored for each assay and subtracted from each time course emission. Ratioing of these two fluorescent emissions provides a fluorescent report of [Ca 2ϩ ] levels that is independent of dye-loading patterns and similar problems. Evaluating this ratio vs. a [Ca 2ϩ ] standard curve prepared in cell homogenates and read on a coverslip with the confocal microscope under identical conditions (pinhole, laser power, objective, emission settings) permitted accurate estimation of [Ca 2ϩ ]int. These values generally agreed with values obtained through identical assays conducted instead with fura 2 and a UV laserequipped Zeiss confocal microscope (Burns and Stehno-Bittel, unpublished data) and are presented as a quantitative estimation of [Ca 2ϩ ]int. Although these assays require additional steps in data processing, the mean population analysis of a field of single cells yields a result that is identical, albeit with better signal-to-noise ratio, to what is measured in a cuvette assay (data not shown). These [Ca 2ϩ ] assays were most reliable when conducted in PSS ϩ 0.2% FBS, because most cells displayed periodic 10 -20% fluctuation in [Ca 2ϩ ]int when studied in DMEM ϩ 0.2% FBS (possibly because of the presence of the ionotropic glutamate receptor channel).
Measurement of E m. The basic method for measuring changes in cellular Em was similar to what we have previously reported (18) and is a modification of Civitelli's original protocol (8) . Subconfluent MG-63 cells grown on coverslips were rinsed with PSS containing 0.2% FBS and then incubated for 40 min in the same medium supplemented with 0.5 M levels of the bis-oxonol dye DiBAC 4(3). As cells polarize, the 500-to 600-nm fluorescent emission from DiBAC 4(3) decreases (5, 8) , and pilot experiments conducted in a quartz cuvette with a Shimadzu RC-5391-PC spectrofluorometer confirmed this phenomenon.
The data reported here were generated by single whole cell assay of E m changes in MG-63 cells plated onto circular 1-mm coverslips with laser-scanning confocal fluorescent microscopy (as above). Excitation was with the 488-nm line of the argon laser (running at 1.5 mW), and the 500-to 620-nm fluorescent emission (620-nm dichroic mirror ϩ 500-nm LP emission filter) was collected. Bis-oxonol dye is not as bright as fluo 4, so a 3-to 3.5-mm pinhole was used, yielding an effective optical slice of ϳ0.8 m when the ϫ40 or ϫ60 objectives were used. These data were collected to permit estimation of relative Em values vs. that of an initial 5-min baseline (see below). Between 8 and 20 cells were studied in each microscopic field. As before, data were collected and stored as time course profiles.
Data analysis. For both assays the specific cellular fluorescence (defined as the total number of bright pixels/cell cross section Ϫ background intensity pixel data) was imported into MicroSoft Excel. Accurate [Ca 2ϩ ] values were obtained as described above. For Em time courses, each data string from a cell was normalized vs. the initial average baseline (average initial fluorescent pixel count/cell over 5 min) to adjust for differences in the area of cellular footprint. It has so far proven impossible to quantitate the DiBAC 4(3) emission against a standard curve to produce quantitative estimation of E m values; thus all Em data are presented as fluorescence intensity of emission as a fraction of the initial value, much as we did previously (18) .
Pooling of single-cell recordings and aggregate analysis. It was important to determine the overall response within a given microscopic field, even if individual cells were heterogeneous in their time course response. Thus the "mean population value" for each time point was determined by averaging the aggregate value from each of the cells being examined in a particular experiment, and this mean value Ϯ SE is plotted for each time point. In this manner, rather complex responses could be analyzed for general parameters and overall properties. It is of interest that the aggregate response of a number of imaged cells (generally when n Ͼ 6 cells) strongly resembles the data obtained from analyzing hundreds of adherent cells in cuvette-sized assays in the spectrofluorometer. Whenever the magnitude of a response with one treatment was evaluated against the magnitude obtained with a different treatment, the area under the curve (AUC) for the corresponding time interval from each result was estimated and directly compared.
Statistical analysis. Time course profiles that are plots of the mean population value determined by averaging the same time point from the individual profiles recorded in 8 -22 individual cells display means Ϯ SE. For every case, the standard deviation is Ͻ5% of the mean value shown. When necessary, mean population values are compared point by point at areas of interest against the basal mean population profile using a simple two-tailed Student's t-test to determine whether the values are different with a statistical significance of P Ͻ 0.05 or better. With regard to multiple comparisons and a single set of controls, comparisons were by one-way ANOVA with group comparisons made by Tukey's test. Again, P Ͻ 0.05 was accepted as significant. To simplify these studies, entire whole cells were measured in our assays. Ratiometric measurement permitted quantitation of results through utilization of a standard [Ca 2ϩ ] curve constructed in cell homogenates prepared from subconfluent basal cultures. Figure 1C presents Fig. 3 , the area under the initial peak of CGRP-stimulated [Ca 2ϩ ] int was calculated and plotted against CGRP dose to determine dose response. A mean population value profile was determined for each concentration of CGRP (as before), and a number of experiments with 0.01-80 nM human CGRP demonstrated a dose-response curve. Maximal effects were obtained by ϳ20 nM, and both 40 and 80 nM CGRP produced substantially less of an increase than 20 nM. Increases were statistically significant at P Ͻ 0.05 (or better) for doses of 0.01 nM CGRP and greater. The apparent EC 50 was ϳ0.25 nM CGRP. The secondary phase [Ca 2ϩ ] int response was also ana-lyzed separately and displayed a very similar EC 50 (data not shown).
RESULTS
Imaging and estimation of CGRP-increased [Ca
Characterization of individual phases of [Ca 2ϩ ] int increase. When cells were pretreated with thapsigargin (10 M; 20 min), the initial CGRP-induced Ca 2ϩ transient was inhibited by ϳ75% at 50 s of CGRP application (P Ͻ 0.001), whereas the secondary delayed phase was not significantly influenced (Fig.  4A) . Pretreatment with verapamil (2 M; 20 min) completely eliminated the second phase while having only minor effects on the initial phase (Fig. 4B) . Similarly, when cells were pretreated with Rp-cAMPS, a potent inhibitor of cAMP-dependent protein kinase (30 M; 20 min), the initial phase was inhibited 27% (without statistical significance) whereas the second phase was eliminated (Fig. 4C) . When cells were preincubated for 20 min with Ca 2ϩ -free PSS ϩ 0.2% FBS supplemented with 1 mM EGTA, the initial phase was only slightly attenuated but the second phase was eliminated (data not shown). As shown in Fig. 5 , when cells were stimulated with CGRP in the presence of CGRP(8 -37) (2 M), a known antagonist of the type 1 CGRP receptor (41), the initial phase was attenuated by ϳ55% (P Ͻ 0.01 vs. CGRP alone) whereas the second phase was nearly eliminated (P Ͻ 0.001 vs. CGRP alone).
Imaging and estimation of E m in single adherent CGRPstimulated MG-63 cells. The vasodilatory effects of CGRP are accounted for by hyperpolarization of cellular E m (30) . In our previous studies (18, 21) , we demonstrated that CGRP can induce membrane hyperpolarization in osteoblastic UMR106 and RCOB-3 rat cells, both of which give only small cAMP responses when stimulated with CGRP. Thus it was of great interest to determine whether CGRP affects E m in MG-63 cells.
Using DiBAC 4 (3) bis-oxonol dye and confocal microscopy, we next monitored the relative cellular E m of single adherent MG-63 cells treated with 10 nM human CGRP (Fig. 6 ). More than 90% of CGRP-stimulated MG-63 cells responded within 50 s and lost ϳ20% of their bis-oxonol fluorescence over 300 s (Fig. 6, B vs. A) . Because bis-oxonol fluorescent emission decreases in parallel with increased negative polarity of cellular E m , these large changes represent significant hyperpolarization of the membrane potential. Unfortunately, it was not possible to quantify the signal from this dye, but DiBAC 4 (3) emission has been reported to decline ϳ25% with a 100-mV shift in E m (5) . Parallel experiments in which vehicle (0.01% trifluoroacetic acid) alone was added demonstrated that no more than a 2-3% decline in DiBAC 4 (3) fluorescent emission normally occurs over 900 s of low-level laser illumination. Figure 6C presents multiple single-cell profiles from an experiment using 11 cells stimulated with 10 nM CGRP. These data are typical of Ͼ15 independent experiments. As observed for CGRP-induced changes in [Ca 2ϩ ] int , considerable heterogeneity was evident between individual single-cell traces, and yet there was an evident pattern to the response. The E m of some cells were observed to oscillate significantly during the experiment, consistent with our observation that ϳ50% of attached MG-63 cells periodically displayed oscillations in E m both before and after application of CGRP.
Averaged time course and dose-response relationship of CGRP-induced E m hyperpolarization in adherent MG-63 cells.
When all single-cell records from independent experiments (with 7-20 cells) were normalized vs. original baseline emission intensities over 5 min (to correct for cellular "footprint"-see MATERIALS AND METHODS) and used to calculate mean population values for each time point, the resulting plot demonstrated the general similarity in the averaged response of the cell population (Fig. 7) . Data from an initial experiment (Fig.  7A ) and summary data from 15 individual experiments examining a total of 180 cells (Fig. 7B ) in which MG-63 cells were stimulated with 20 nM human CGRP proved to be very similar. The vast majority of cells responded by 50 s to 20 nM human CGRP with a steep initial drop in bis-oxonol fluorescence, a partial reversal, and then a second steep drop to yield maximal reduction in fluorescence after ϳ300 s. Hyperpolarization of E m was sustained for at least 600 s.
As with the [Ca 2ϩ ] int assay, multiple doses of human CGRP were used to construct a dose-response curve (net decrease in bis-oxonol emission at the 300 s point plotted against peptide concentration). Just as observed for stimulation of [Ca 2ϩ ] int , maximal effect was obtained with 20 nM CGRP and less of an effect was obtained with 40 -80 nM. The EC 50 was ϳ0.30 nM (data not shown).
Characterization of CGRP-induced E m hyperpolarization.
A number of multicell experiments were performed using the maximally effective dose of CGRP (20 nM) with standard concentrations of specific or selective inhibitors to determine the involvement of different pathways or membrane channels in CGRP-induced hyperpolarization of E m (Fig. 8) . Rp-cAMPS (30 M; 20-min pretreatment) produced an 8% reduction in effect 300 s after treatment that was not statistically significant; however, it did significantly delay the onset of E m polarization, possibly by eliminating the initial phase of polarization. A selective inhibitor of Ca 2ϩ -activated K ϩ (K Ca ) channels, charybdotoxin (5 g/ml; 5-min pretreatment), attenuated CGRP-induced reduction in bis-oxonol emission by 20% (with P Ͻ 0.05 vs. CGRP alone), whereas a specific inhibitor of ATP-sensitive K ϩ (K ATP ) channels, glyburide (1 M; 5-min pretreatment), blocked it by ϳ83% (P Ͻ 0.001).
Hints of a second receptor subtype. Several results hinted at the presence of a second CGRP receptor subtype: CGRP(8 -37) (2 M) significantly delayed the initial phase of E m polarization and produced a general 55% inhibition of the overall effect at 300 s after treatment (P Ͻ 0.01 vs. CGRP alone; data not shown); the same compound produced a 75% inhibition of the cAMP formation induced by 20 nM CGRP (22) . As shown above (Fig. 5C ), CGRP(8 -37) also inhibited the initial Ca 2ϩ peak while eliminating the cAMP-dependent secondary-phase Ca 2ϩ increase. However, available experimental data do not confirm the presence of a second type of CGRP receptor.
DISCUSSION
With careful perusal of published data, there should be little doubt that CGRP can act directly on osteoblastic cells to increase bone mass, but the literature also displays a wide variation in CGRP-induced signaling observed within different types of osteogenic cells. In fact, it is widely believed that mature osteoblastic cells downregulate CGRP receptors as they differentiate and no longer respond to CGRP-because strong stimulation of cAMP formation is not always observed in mature osteoblastic models. This view stems directly from the assumption that CGRP action in osteogenic cells is mediated predominantly by cAMP-dependent signaling pathway(s). Thus the actual mechanism of action behind CGRP's stimulation of immature and mature osteogenic cells is a question central to the basic issue of whether CGRP plays a bone anabolic role.
In investigating this concept, we previously studied the effects of CGRP on [Ca 2ϩ ] int and E m in mature osteoblastic rat UMR106 (18, 20, 21) and RCOB-3 (20) cells. CGRP did not elicit large increases in cAMP production (Kawase and Burns, unpublished observations), whereas it did invoke sizable Ca 2ϩ transients and E m hyperpolarization in UMR106 (18, 20, 21) and RCOB-3 cells (Ref. 20 ; Ca 2ϩ data not published). This is consistent with a subsequent demonstration (6) that UMR106 cells do not seem to express the type 1 CGRP receptor (which generally couples tightly to adenylate cyclase activation). Thus these findings and demonstration of similar strong cAMPindependent CGRP signaling in other mature osteoblastic cell lines (11, 12) and primary human osteoblasts (38, 39) strongly suggested that cAMP-dependent signaling pathways are no longer the predominant mediators of CGRP action in mature osteoblastic cells (18) . On the basis of previous data (3, 28, 34) , the converse argument could also be made-that cAMP-dependent signaling pathways predominate in immature osteogenic cells.
We have now tested in preosteoblastic human MG-63 cells the working hypothesis that cAMP-dependent mechanisms would predominate without appreciable contribution from cAMP-independent signaling pathways. MG-63 cells were previously shown to strongly express mRNA for one of the components (CRLR) of a type 1 CGRP receptor (35) . We recently demonstrated (22) the expression of both CRLR and RAMP1 proteins in these cells and determined that CGRP strongly stimulates cAMP formation. We could not detect expression of multiple CGRP receptors by analyzing saturation-binding kinetics with 125 I-His 10 -labeled human CGRP during the course of these studies (22) . On the basis of these data, we assumed that only one receptor subtype was present and that it would predominantly signal through cAMP-dependent pathways. Thus we investigated [Ca 2ϩ ] int and E m values during CGRP treatment just to verify that no changes occurred. As shown in the present study, CGRP produces strong changes in both these parameters. The results reported here show both unexpected similarities to and surprising differences from our data from UMR106 cells, and, on evaluation, these data require that we discard or reformulate our simple hypothesis.
With regard to methodology, we have in the present study introduced and successfully adapted the dual-dye confocal fluorescent microscopy method of Lipp and Niggli (25, 26) to assay [Ca 2ϩ ] int within single human preosteoblastic MG-63 cells. Applying similar protocols has also greatly improved our established bis-oxonol assay of relative cellular E m . To simplify these complex actions, we have only considered individual whole cells; future studies will need to examine apparent subcellular changes visualized by fluorescent imaging within A and B: these confocal images have been pseudocolored to demonstrate the ϳ18% reduction in bis-oxonol signal intensity produced by CGRP. A: nonstimulated MG-63 cells. B: administration of 10 nM CGRP induced significant decreases in bis-oxonol emission after 300 s. C: by recording emissions from nonstimulated dye-loaded individual cells every 7 s over 5 min to establish a baseline Em for each cell, it is possible to chart time courses detailing CGRP's effects by plotting fraction of (average) basal emission intensity vs. time. CGRP addition is indicated by the arrow, and 11 individual cellular traces were followed in this experiment. Cellular heterogeneity is evident in these traces, and several cells displayed periodic oscillations in Em. Very similar data have been obtained in a total of 15 independent multicell experiments. FI, fluorescence intensity. these cells. We have now measured large and complex CGRPinduced changes in [Ca 2ϩ ] int and cellular E m that were not predicted from our working hypothesis.
CGRP-induced two-phase changes in [Ca 2ϩ ] int over time and mechanism of action. In human osteoblastic OSH-4 cells, CGRP was shown to induce a 2.3-fold initial peak in [Ca 2ϩ ] int that lasts for Ͼ30 s before subsiding into a sustained plateau maintained at 140% of basal levels for an additional Ͼ60 s (11, 12) . Such a response to CGRP had not previously been shown, because in our studies of rat osteoblastic UMR106 cells, CGRP elicited only simple 30-to 45-s Ca 2ϩ transient peaks that quickly subsided (20) . In the present study, the Ca 2ϩ increase in CGRP-treated MG-63 cells featured both a large initial transient and a subsequent sustained phase. This two-phase profile itself is similar to that obtained from CGRP-treated OHS-4 cells and is very similar to that induced by parathyroid hormone (PTH) in UMR106 cells (43, 44) .
The initial transient peak was inhibited 75% by thapsigargin but not substantially affected by extracellular EGTA or RpcAMPS, indicating that this response is primarily produced by Ca 2ϩ release from intracellular stores in a cAMP-independent manner. However, because thapsigargin showed an incomplete elimination of this phase and both EGTA and verapamil produced a small inhibition, there may be a small contribution to the initial phase (perhaps 15-25% of the total effect) through very rapid transmembrane Ca 2ϩ influx as has been shown for PTH (44) .
In contrast, the second sustained phase of elevated [Ca 2ϩ ] int in MG-63 cells was not appreciably sensitive to thapsigargin but was inhibited by extracellular EGTA and verapamil. This phase was also inhibited by Rp-cAMPS and compound H-89 (data not shown) and eliminated by 2 M CGRP (8 -37) . These data suggest that, in the second phase, activated CGRP receptors stimulate Ca 2ϩ influx through a voltage-dependent Ca 2ϩ channel and this process is initiated by cAMP and further integrated by cAMP signaling pathways. Similarly, in PTHtreated UMR106 cells, the slow secondary phase was demonstrated to be mediated by a cAMP-dependent, verapamilsensitive membrane Ca 2ϩ channel (44) . In addition, the secondary phase observed in CGRP-treated OHS-4 cells, which is substantially smaller than that obtained here, was also shown to result from transmembrane influx as it was nifedipine sensitive; however, the secondary phase in OHS-4 cells is cAMP independent (11, 12) .
CGRP-induced membrane hyperpolarization in MG-63 cells. Compared with Ca
2ϩ mobilization, CGRP action on E m has rarely been studied in osteoblastic cells at any stage of differentiation. In our previous study (18), we for the first time demonstrated with standard cuvette assays that CGRP induces membrane hyperpolarization in adherent UMR106 cells. Judging from the dose-response relationship and the very small cAMP response elicited by CGRP in these cells, we suggested that cAMP-dependent signaling pathways were not involved in this action. In the present study of human preosteoblastic MG-63 cells using more sensitive protocols, we were surprised to find very similar time course profiles and dose-response relationships.
This action was further characterized with several specific pharmacological inhibitors. Rp-cAMPS delayed or suppressed the most initial transient phase of E m polarization but failed to significantly inhibit the sustained phase. Conversely, glyburide almost completely blocked the second phase but not the initial phase, whereas charybdotoxin showed only slight effects on either phase. Therefore, these findings suggest that the initial phase is induced by a cAMP-dependent mechanism (possibly the rapid opening and closing of a Cl Ϫ channel) and the large sustained major phase is produced by activating cAMP-independent K ATP channels. However, our experiments do not rule out the possibility that either phase is also somewhat influenced by a Ca 2ϩ -dependent mechanism. Hints of a second CGRP receptor subtype. CGRP(8 -37) has been described as a selective antagonist of type 1 CGRP receptors. CGRP(8 -37) was able to eliminate certain effects (secondary phase of increased [Ca 2ϩ ] int ; Fig. 5C ) while only attenuating other effects by 55% [initial Ca 2ϩ peak (Fig. 5C ) and the bulk of cellular E m polarization (Fig. 8)] . Although modest, the differences in level of inhibition between the two sets of effects did suggest that different receptors could be involved in this process. Unfortunately, careful analysis of the recent literature reveals several reports (40, 42) questioning how selective CGRP(8 -37) actually proves to be (31) . Because these pharmacological differences are the major reason to propose the existence of multiple subtypes of CGRP receptor (31) , this ambiguity has led Abel and coworkers (40) to propose that type 2 receptors essentially represent a pharmacological illusion reflecting receptor number and the efficiency with which receptor is coupled to the intracellular transduction machinery. Considerably more work will be required to generate definitive data that determine whether a type 2 receptor is expressed on MG-63 cells.
Proposed explanation and scheme. Our best interpretation of the data described and discussed here is summarized in Fig. 9 , which indicates the different signaling pathways and effector molecules used by CGRP in MG-63 cells. The simplest explanation is that a type 1 CGRP receptor concomitantly couples to two or more different effector pathways in MG-63 cells. What would once have seemed an unlikely explanation is now supported by the literature, which indicates that transfected CGRP receptors can concomitantly signal by increasing both cAMP and Ca 2ϩ (24, 31) . Dual signaling has also been shown for the primary calcitonin receptor (31) . Typically, changes in E m have not been followed, and the exact mechanism(s) by which cellular E m is modulated in osteogenic cells remains to be identified.
In conclusion, the present study provides data describing the activation of signaling pathways in an immature preosteoblastic human cell. Despite our initial working hypothesis, CGRP still induced strong ion-associated signaling by cAMP-independent mechanism(s). Although cAMP clearly plays a more important role in MG-63 cells than it does in UMR106 cells (18, 20, 21) , cAMP-independent pathways are obviously important. Improvements on current assay protocols will undoubtedly enable more detailed study of CGRP-induced cellular changes.
These data further support the basic concept that bone is an important target tissue for the peripheral nervous system (13, 14, 16, 17, 27) . Combined with our previous data (18, 20 -22) , these data provide a number of notable findings that collectively improve our understanding of CGRP-activated signaling pathways in osteoblastic cells. Fig. 9 . A simple explanation of CGRP signaling in MG-63 cells. This explanatory scheme explains CGRP action in these cells by illustrating how a type 1 CGRP receptor (CGRP-R1) could simultaneously couple to 2 (or more) different G proteins to produce the diverse effects observed. We have demonstrated a type 1 CGRP receptor expressed on the surface of MG-63 cells (22) , and this receptor subtype is well known for being coupled through a Gs protein to adenylate cyclase and stimulating cAMP formation, consistent with our observation of a 35-fold CGRP-induced increase in cAMP in these cells (22) . The cAMP-dependent arm of signaling is clearly involved in opening membrane verapamil (Ver)-sensitive membrane Ca 2ϩ channels to produce the cAMP-dependent, RP-cAMPS-sensitive secondary sustained rise in [Ca 2ϩ ]. The cAMP-independent arm of CGRP signaling in MG-63 cells could be mediated by concomitant interaction with a dual-function Gq or Gi regulatory protein to produce the initial peak of elevated [Ca 2ϩ ]int by mobilizing thapsigargin (Thap)-sensitive intracellular Ca 2ϩ stores. Similarly, we suggest that this second G protein is also responsible for cAMP-independent polarization of cellular Em through activation of glyburide (Gly)-sensitive ATP-dependent K 
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